Evidence map›Paper›PMID 41120219›Full record

ArticleBritish journal of sports medicine2025

Association between frequency of meeting daily step thresholds and all-cause mortality and cardiovascular disease in older women.

Rikuta Hamaya, Kelly R Evenson, Daniel Lieberman, I-Min Lee

Abstract read
In one paragraph

Article in British journal of sports medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Rikuta HamayaDepartment of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA rhamaya@bwh.harvard.edu.ORCID http://orcid.org/0009-0001-2129-8956
Kelly R EvensonEpidemiology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.ORCID http://orcid.org/0000-0002-3720-5830
Daniel LiebermanHuman Evolution Biol, Harvard University, Cambridge, Massachusetts, USA.ORCID http://orcid.org/0000-0002-6194-9127
I-Min LeeBrigham and Women's Hospital, Boston, Massachusetts, USA.ORCID http://orcid.org/0000-0002-1083-6907

Funding

Women's Health Study: Continued Follow-upR01CA047988 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI BURING, JULIE E., LEE, I-MIN · 1991 to 2014
$28.2M
Women's Health Study: Continued Follow-UpR01HL080467 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI BURING, JULIE E. · 2005 to 2010
$4.5M
Women's Health Study: Infrastructure support for continued cohort follow-upU01CA182913 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI BURING, JULIE E., LEE, I-MIN · 2019 to 2023
$4.0M
The Women's Health Study: Infrastructure Support for Continued Cohort Follow-upUM1CA182913 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI BURING, JULIE E., LEE, I-MIN · 2014 to 2018
$4.0M
Physical Activity, Sedentary Behavior, and Cancer Incidence in WomenR01CA227122 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI EVENSON, KELLY R. · 2019 to 2022
$2.7M
TRIAL OF VITAMIN E, BETA-CAROTENE &ASPRIN IN WOMENR01HL043851 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI BURING, JULIE E · 1991 to 2000
$1.6M
Objectively Measured Physical Activity and Mortality in WomenR01CA154647 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI LEE, I-MIN · 2011 to 2014
$1.2M
The Women's Health Study: Addition of New Data to Maximize its Research ImpactRC1HL099355 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI BURING, JULIE E. · 2009 to 2010
$992k
NCI NIH HHS R01 CA047988NCI NIH HHS R01 CA154647NCI NIH HHS R01 CA227122NCI NIH HHS U01 CA182913NCI NIH HHS UM1 CA182913NHLBI NIH HHS R01 HL043851NHLBI NIH HHS R01 HL080467NHLBI NIH HHS RC1 HL099355
6 · The paper itself

Abstract

objectiveTo examine the associations between the number of days per week achieving various daily step thresholds and all-cause mortality and cardiovascular disease (CVD) incidence in older women.

methodsWe conducted a prospective cohort study of 13 547 women free of CVD and cancer (mean age 71.8 years). We included participants who wore an ActiGraph GT3X+ accelerometer for 7 consecutive days between 2011-2015 and were subsequently followed for mortality through 2024. Women were classified by the number of days per week achieving step thresholds of ≥4000, ≥5000, ≥6000 or ≥7000 steps/day. Cox proportional hazards regression estimated hazard ratios (HR) and 95% confidence intervals (95% CI) for all-cause mortality and CVD incidence, adjusting for lifestyle behaviours and comorbidities.

resultsDuring a median follow-up of 10.9 years, 1765 women (13.0%) died and 781 (5.1%) developed CVD. Achieving ≥4000 steps/day on 1-2 and ≥3 days/week was associated with lower mortality risk compared with 0 days/week (adjusted HR 0.74 (95% CI 0.65 to 0.86) and 0.60 (95% CI 0.53 to 0.68), respectively). For CVD, corresponding results were 0.73 (95% CI 0.58 to 0.92) and 0.73 (95% CI 60 to 0.89), respectively. An inverse curvilinear dose-response relationship was observed for mortality, such that with higher step thresholds (5000, 6000 or 7000), the risk of mortality further declined modestly. With additional adjustment for mean daily steps, associations were attenuated to the null.

conclusionsAmong older women, achieving ≥4000 steps/day on even 1-2 days/week was associated with lower mortality and CVD, while more steps were associated with even better outcomes. A greater number of steps, regardless of daily patterns, is associated with better health outcomes.

Indexed as

Cardiovascular DiseasesExerciseAccelerometryAgedAged, 80 and overCause of DeathFemaleHumansIncidenceProportional Hazards ModelsProspective StudiesPhysical activity

Identifiers

PMID41120219
PMCPMC12747423

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.